MacroGenics | MGNX - Gastos De Venta Y Administración

Precio De Mercado
3.19
Cambio Diario
0.01 0.31%
Mensual
0.63%
Anual
86.55%
Q2 Expectativa
3.12




Gastos De Venta Y Administración Cambio Fecha
AbbVie USD 3.89B 325M 2025-12
Amgen USD 1.94B 237M 2025-12
AstraZeneca USD 4.61B 4.46B 2025-12
Biogen USD 545.2M 38.6M 2025-09
Bristol-Myers Squibb USD 2.18B 392M 2025-12
Daiichi Sankyo JPY 228.23B 39.15B 2025-12
Eli Lilly USD 3.13B 391.3M 2025-12
Genmab DKK 208M 60M 2025-12
Geron USD 41.67M 2.67M 2025-12
Gilead Sciences USD 1.78B 425M 2025-12
J&J USD 6.03B 719M 2026-03
Karyopharm Therapeutics USD 9.56M 17.63M 2025-12
MacroGenics USD 7.94M 1.96M 2025-12
Merck USD 2.85B 215M 2025-12
Pfizer USD 4.08B 894M 2025-12
Puma Biotechnology USD 16.82M 8.15M 2024-09
Regeneron Pharmaceuticals USD 775M 117.2M 2025-12
Roche Holding CHF 7.28B 3.99B 2025-12
Xencor USD 17.04M 70.74M 2025-12